Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study

Collaboration

Year: 2024

Diaz-Villamarin, X; Martinez-Perez, M; Nieto-Sanchez, M; Ruiz-Tueros, G; Fernandez-Varon, E; Torres-Garcia, A; Astorga, B.G.; Blancas, I; Iañez, A.J.; Cabeza-Barrera, J; Moron, R.

Title: PHARMACEUTICS

• Q1